新手上路
二星級會員
- 舊站積分
- 54
- 舊站發表文章數
- 304
|
樓主 |
發表於 2021-11-7 22:53:14
|
顯示全部樓層
【華府衝擊播】專訪mRNA疫苗技術發明人Robert Malone:疫苗政策缺乏科學依據
https://www.ntdtv.com/b5/2021/11/06/a103262299.html
【新唐人021年11月07日訊】美國病毒學家和免疫學家、mRNA疫苗技術發明人之一羅伯特‧馬龍,近日再次接受英文大紀元專訪時表示,他對疫苗有信心,但質疑整個疫苗政策背棄道德及科學,他還表示疫苗不是打越多越好。
mRNA疫苗技術發明人Robert Malone:「我們需要面對數據本身,不要試圖掩蓋事實或隱瞞風險。」
羅伯特·華萊士·馬龍主要研究mRNA技術、藥物和藥物再利用,是mRNA疫苗技術發明人之一。
他表示對疫苗有信心,但質疑美國推出第三劑加強劑沒有科學根據,這一點CDC也承認了。
mRNA疫苗技術發明人Robert Malone:「有一次疾控中心主任接受一個關鍵採訪,記者問她:『我們有什麼數據嗎?我們有數據嗎?還是我們只對第三劑的好處抱有希望?』值得讚揚的是,她承認我們沒有數據,我們所擁有的只是希望。」
馬龍表示,問題就在這兒。疫苗反應不是線性的,不是越多越好。
mRNA疫苗技術發明人Robert Malone:「在很多情況下,如果劑量更多或更頻繁,或者超出第一劑和加強劑,你實際上可以抑制免疫反應。你可以進入『高容忍區』,可以進入免疫反應下降的情況。」
馬龍說,如果這份報告能展開,將會驗證在自然感染後,接種一劑疫苗是好事,第二劑就是壞事。因為疫苗本來是預防感染,防止傳播的,但現在接種疫苗的人也會感染,情況就複雜了。
馬龍以瑞典為例,證實自然免疫的功效。
mRNA疫苗技術發明人Robert Malone:「現在,Delta在該地區移動,他們的死亡率非常低,與一些沒有採取這一政策的鄰國相比,他們的死亡率經常是零,也沒有這麼廣泛的自然感染。比如芬蘭,他們非常積極地部署了疫苗,而且接種效果很好,他們的疫苗呈指數增長曲線,就像其他北歐國家一樣。」
馬龍認為,在疫苗管理、測試以及使用方面,應該保持多年來形成的規範。
mRNA 疫苗先驅 Robert Malone:「我是過來人,我堅信,過去三、四十年在疫苗學中制定的規範應該保持。我們不能因為遇到危機就拋棄它們。」
新唐人記者紐約報導[/SIZE]
<iframe src="https://www.youmaker.com/embed/f9ac743f-84ee-41fc-8eea-ce32c9084853?r=16x9&d=173" width="800" height="450" frameborder="0" allowfullscreen playsinline></iframe>
這翻譯,有點故意歐!
https://www.theepochtimes.com/dr ... sensus_3979206.html
<iframe id="lbry-iframe" width="800" height="450" src="https://odysee.com/$/embed/DR-ROBERT-MALONE-AMERICAN-THOUGHT-LEADERS1/1f3b2168ff376c4a24607ed02c9a3b1ae74144d1?t=2059&r=5eYPwcfBLYkHqyWofuq2JFMsRkGGYVyu" allowfullscreen></iframe>
17:20
"But now, additional adverse events, and things that we discussed when we had our last chat as parent adverse events, these are now fairly well-documented in this New England Journal article, things like viral reactivation. So this is the shingles, for instance.
The paper attempts to make the case that, 「The vaccines have a lot of adverse events, but the disease has a lot of adverse events also, and the disease is worse. Also there』s a lot of overlap between these adverse events associated with the disease and the vaccine.」 But the messaging was focused in that manuscript that it was far worse to get the disease than to have the adverse events associated with the vaccine. "
34:19
"But what they (Sweden) did do was have a lot more natural infection with alpha and beta strains. And now that Delta is moving through the region, they have an extremely low mortality rate, often hitting zero on any one day—in comparison to some of their neighbors that didn』t take that policy, and didn』t have such widespread natural infection. Like Finland, for example, where they deployed vaccine very avidly and had good uptake, they』re having the exponential growth rate curve that』s happening in many other Northern European countries right now."
[/SIZE] |
|